fluorescent s aureus atcc 49230 strain (ATCC)
Structured Review
Fluorescent S Aureus Atcc 49230 Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 899 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/atcc+strains/Staphylococcus+aureus+subsp%2E+aureus+Rosenbach/10__22203_slash_ecm__v033a11-80-21-24
Average 99 stars, based on 899 article reviews
Images
Related Articles
other:Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Article Title: Analysis of the antimicrobial activity of zinc oxide nanoparticles against drug-resistant bacteria and their applications in the disinfection process Article Snippet: Activity Assay:Article Title: Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection. Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) causes severe bacterial pneumonia; current therapies (e.g., vancomycin) suffer from poor pulmonary bioavailability and dose-limiting safety concerns, demanding precision lung-enriched agents.. However, small-molecule lung-enriched antibacterials are relatively rare.. Honokiol (HNK), a natural phenolic compound with broad pharmacological activities but moderate antibacterial potency and limited tissue selectivity, was selected as the scaffold. Concentration Assay:Article Title: Design, synthesis, and optimization of Honokiol-Piperazine derivatives as lung-enriched agents against MRSA pneumonia infection. Article Snippet: Methicillin-resistant Staphylococcus aureus (MRSA) causes severe bacterial pneumonia; current therapies (e.g., vancomycin) suffer from poor pulmonary bioavailability and dose-limiting safety concerns, demanding precision lung-enriched agents.. However, small-molecule lung-enriched antibacterials are relatively rare.. Honokiol (HNK), a natural phenolic compound with broad pharmacological activities but moderate antibacterial potency and limited tissue selectivity, was selected as the scaffold. |
